GlassScriptPhysician profile
Sivakumar Sudhakaran
NPI 1154854628
$8,022.12
in general payments reported to CMS, 2019-2025
14 companies · $5,360 in 2025
The $5,360 reported for 2025 was more than what 84% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $25.12 · 2023: $1,425 · 2024: $1,211 · 2025: $5,360.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $4,597 · Food and Beverage: $3,399 · Education: $1.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $4,596.62 |
| Food and Beverage | $3,399.38 |
| Education | $1.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $3,606.59 | 2024-2025 | Sapien 3 Ultra Resilia, Evoque, Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Philips North America LLC | $2,000.97 | 2025 | Igt Devices Undivided |
| Abbott Laboratories | $632.05 | 2023-2025 | Mitraclip, Amplatzer Amulet, Diamondback Coronary |
| Boston Scientific Corporation | $321.22 | 2023-2024 | Versacross Access Solution |
| Medtronic, INC. | $297.84 | 2023-2025 | Resolute Onyx, Corevalve Evolut R, Selectsecure |
| W. L. Gore & Associates, INC. | $267.46 | 2023-2025 | Gore Viabahn Endoprosthesis With Heparin, Gore Cardioform Septal Occluder |
| Penumbra, INC. | $213.77 | 2023 | Indigo System |
| Shockwave Medical, INC | $208.23 | 2023 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Abiomed | $127.07 | 2025 | |
| Cordis US Corp. | $102.06 | 2023 | Mynx Control |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $99.79 | 2023 | Lifevest |
| Cathworks, INC. | $84.12 | 2023 | Ffrangio |
| Amgen INC. | $35.83 | 2023 | Repatha |
| Pfizer INC. | $25.12 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sivakumar Sudhakaran listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.